R E Law
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- NF-κB Signaling Pathways 2
- Protease and Inhibitor Mechanisms 2
-
- T-cell and Retrovirus Studies 2
- Immune Response and Inflammation 2
- Co-authors
- Willa A. Hsueh (3 shared papers)David P. Faxon (1 shared paper)Daniel A. Wuthrich (1 shared paper)William D. Coats (1 shared paper)K. Graf (1 shared paper)Woerner P. Meehan (1 shared paper)Fen Yin (1 shared paper)André J. Van Herle (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (3 papers)Molecular and Cellular Biology (2 papers)Journal of Investigative Medicine (1 paper)Journal of Surgical Research (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
R E Law
20 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 248
- Biochemistry 87
- Virology 53
- Molecular Biology 781
- Pharmacology 181
Countries citing papers authored by R E Law
This map shows the geographic impact of R E Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R E Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R E Law more than expected).
Fields of papers citing papers by R E Law
This network shows the impact of papers produced by R E Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R E Law. The network helps show where R E Law may publish in the future.
Co-authors
The 25 scholars most cited alongside R E Law, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 443 | |
| 2 | Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. | 2001 | 164 |
| 3 | 1994 | 161 | |
| 4 | Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. | 2000 | 159 |
| 5 | 1995 | 134 | |
| 6 | 1994 | 64 | |
| 7 | 1992 | 49 | |
| 8 | 1995 | 37 | |
| 9 | 1987 | 34 | |
| 10 | 2002 | 32 | |
| 11 | 2005 | 29 | |
| 12 | 1998 | 25 | |
| 13 | 1993 | 22 | |
| 14 | 1994 | 21 | |
| 15 | 2002 | 15 | |
| 16 | 1996 | 12 | |
| 17 | 1990 | 12 | |
| 18 | 2008 | 5 | |
| 19 | 1980 | 2 | |
| 20 | Peroxisome Proliferator-Activated Receptors and diabetic vasculature | 2004 | 1 |
About R E Law
R E Law is a scholar working on Cancer Research, Immunology, Molecular Biology, Pharmacology and Biochemistry, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (3 papers), Lipoproteins and Cardiovascular Health (2 papers), NF-κB Signaling Pathways (2 papers), Protease and Inhibitor Mechanisms (2 papers), Cancer-related gene regulation (2 papers), Nuclear Receptors and Signaling (2 papers), T-cell and Retrovirus Studies (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Cancer Research (248 citations), Biochemistry (87 citations), Virology (53 citations), Molecular Biology (781 citations) and Pharmacology (181 citations). R E Law has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Willa A. Hsueh, David P. Faxon, Daniel A. Wuthrich, William D. Coats, K. Graf, Woerner P. Meehan, Fen Yin, André J. Van Herle, David R. Hinton and William T. Couldwell. Their work appears in journals such as Biochemical and Biophysical Research Communications, Molecular and Cellular Biology, Journal of Investigative Medicine, Journal of Surgical Research and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.